Top

Published in:

01-07-2019 | Metastasis | Gastrointestinal Oncology

It Is Time

Authors: Kiran K. Turaga, MD, MPH, T. Clark Gamblin, MD, MS, MBA, Robert Edwards, MD, PhD, H. Richard Alexander, MD, PhD, David Bartlett, MD

Published in: Annals of Surgical Oncology | Issue 7/2019

Excerpt

In this series, we present selected articles presented at the SSO International Symposium of Regional Therapies at Jacksonville in 2018. The symposium, which was supported by the Society of Surgical Oncology, resulted in a record turnout and a great scientific discussion. In addition to laying grounds for scientific advances and collaboration, the meeting provided a family–friendly venue for networking, mentoring, and new ideas. …

Perez MC, Miura JT, Naqvi SMH, et al. Talimogene Laherparepvec (TVEC) for the treatment of advanced melanoma: a single-institution experience. Ann Surg Oncol. 2018;25:3960. https://doi.org/10.1245/s10434-018-6803-0.CrossRefPubMed

Silva JP, Klooster B, Tsai S, et al. Elective regional therapy treatment for hepatic adenoma. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-6802-1.

Roxburgh CS, Fenig YM, Cercek A, et al. Outcomes of low-grade appendiceal mucinous neoplasms with remote acellular mucinous peritoneal deposits. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-7003-7.

Munoz-Zuluaga C, Sardi A, King MC, et al. Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-7007-3.

Katsarelias D, Rådbo E, Ben-Shabat I, et al. The effect of temperature and perfusion time on response, toxicity, and survival in patients with in-transit melanoma metastases treated with isolated limb perfusion. Ann Surg Oncol. 2018;25:1836. https://doi.org/10.1245/s10434-018-6459-9.CrossRefPubMedCentralPubMed

Belgrano V, Pettersson J, Nilsson JA, et al. Response and toxicity of repeated isolated limb perfusion (re-ILP) for patients with in-transit metastases of malignant melanoma. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-018-07143-4.

Hendrix RJ, Damle A, Williams C, et al. Restrictive intraoperative fluid therapy is associated with decreased morbidity and length of stay following hyperthermic intraperitoneal chemoperfusion. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-07092-y.

Anghelescu DL, Brown CL, Murphy AJ, et al. Anesthesia and pain management for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for desmoplastic small round cell tumors in children, adolescents, and young adults. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-6808-8.

Choudry MHA, Shuai Y, Jones HL, et al. Postoperative complications independently predict cancer-related survival in peritoneal malignancies. Ann Surg Oncol. 2018;25:3950. https://doi.org/10.1245/s10434-018-6823-9.CrossRefPubMed

10.

Beane JD, Wilson GC, Sutton JM, et al. Pleuropulmonary recurrence following cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for appendiceal Pseudomyxoma peritonei. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-018-07091-z.

11.

Feferman Y, Solomon D, Bhagwandin S, et al. Sites of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis from colorectal and appendiceal adenocarcinoma: a tertiary center experience. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-6860-4.

12.

Francescutti VA, Maciver AH, Stewart E, et al. Characterizing the patient experience of CS/HIPEC through in-depth interviews with patients: identification of key concepts in the development of a patient-centered program. Ann Surg Oncol. 2019. https://doi.org/10.1245/s10434-018-07120-x.

13.

Votanopoulos KI, Mazzocchi A, Sivakumar H, et al. Appendiceal cancer patient-specific tumor organoid model for predicting chemotherapy efficacy prior to initiation of treatment: a feasibility study. Ann Surg Oncol. 2018. https://doi.org/10.1245/s10434-018-7008-2.

Title: It Is Time
Authors: Kiran K. Turaga, MD, MPH
T. Clark Gamblin, MD, MS, MBA
Robert Edwards, MD, PhD
H. Richard Alexander, MD, PhD
David Bartlett, MD
Publication date: 01-07-2019
Publisher: Springer International Publishing
Keyword: Metastasis
Published in: Annals of Surgical Oncology / Issue 7/2019
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-019-07207-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

It Is Time

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2019

Population-Based Study on Risk Factors for Tumor-Positive Resection Margins in Patients with Gastric Cancer

Borderline and Malignant Phyllodes Tumors: How Often do They Locally Recur and is There Anything we can do About it?

Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database

Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival

Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database

Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor